Pharmaceutical Intermediates Market Is Expected to Pegged Around US$ 32,180 Mn by 2023

Pharmaceutical Intermediates Market is Expected to Pegged around US$ 32,180 Mn by 2023, Due to Surge in Pharma Production Coupled with Increased Exports of API


London, London -- (SBWire) -- 11/10/2018 --Analyst Speak:

"The Pharmaceutical Intermediates Market is anticipated to reach about US$ 32,180 Mn by 2023, and anticipated to expand at a CAGR over six years of forecast period 2018-2023 owing to surge in the production of pharmaceuticals coupled with the increased exports of APIs.

Precision Business Insights (PBI) in its report titled "Pharmaceutical Intermediates Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period from 2018 to 2023. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Pharmaceutical Intermediates market size was accounted for US$ 26,457.0 Mn in 2018 and anticipated to account for US$ 32,180.0 Mn by 2023. Increased prevalence of chronic diseases will create demand for novel active pharmaceutical ingredients (API). Surge in the pharmaceutical production enables stimulate the demand for pharmaceutical intermediates. Moreover, Escalated exports of APIs will also enhance the demand for pharmaceutical intermediates.

Sample of this report is available upon request:

Pharmaceutical Intermediates market segmented on the basis of application, end-user and country

Cardiovascular Drugs Segment Expected to Dominate the Market

Based on Application Type, The Pharmaceutical Intermediates market is segmented as anti-infective drugs, cardiovascular drugs, central nervous system drugs, anti-diabetic drugs, anti-ulcerants, and others. Cardiovascular drugs segment has been witnessed to account for major revenue share over the forecast period. The API intermediates are raw materials which are responsible for therapeutic action. These can be converted into the desired formulations such as capsules, tablets, and others.

Pharmaceutical Companies Will Dominate the Revenue Share.

Based on end-user type, pharmaceutical intermediates market segmented into pharmaceutical companies, research laboratories, contract manufacturing organizations, and others. The pharmaceutical companies are witnessed to account for major revenue share over the forecast period.

Asia-Pacific, Accounts for Major Revenue Share for Pharmaceutical Intermediates Market

Precision Business Insights (PBI) Pharmaceutical Intermediates market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, Asia Pacific accounted for major revenue share due to increased R&D investments in China and India. Surge in the pharmaceutical production coupled with increased exports are witnessed to offer lucrative opportunities for the market players plunged in the pharmaceutical intermediates market.

U.S. Pharmaceutical Intermediates market is accounted for major revenue share in North America, owing to increased pharmaceutical production and robust investments in R&D.

TOC of this report is available upon request @

Strategic Collaborations & Exports Play Vital Role in Pharmaceutical Intermediates Market

The increased R&D investment from pharmaceutical companies, research organizations and biotech companies are expected to create demand for pharmaceutical intermediates. Key player's profiles in the report are Aceto Corporation, BASF SE, Vertellus Holdings LLC, Lianhetech, Easter Chemical Corporation, Cycle Pharma Chem, Dishman Group, Dextra Laboratories Limited, Chemcon Specialty Chemical Pvt. Ltd, Midas Pharma GmbH, Codexis, A.R. Life Sciences Private Limited, Sanofi Winthrop Industries, and ZCL Chemical Ltd among others.

Ask Analyst for Full Information about this report @

Detailed Segmentation

By Application Type

o Anti-Infective Drugs
o Cardiovascular Drugs
o Central Nervous System Drugs
o Anti-diabetic Drugs
o Anti-Ulcerants
o Others

By End-User Type

o Pharmaceutical Companies
o Research Labs
o Contract Manufacturing Organizations
o Other Industries


o North America
? U.S.
? Canada

o Europe
? Germany
? UK
? France
? Russia
? Spain
? Italy
? Rest of Europe

o Asia-Pacific
? China
? Japan
? India
? Rest of Asia Pacific

o Latin America
? Brazil
? Mexico
? Argentina
? Chile
? Rest of Latin America

o Middle East and Africa
? South Africa
? Saudi Arabia
? Rest of MEA

Get access to full summary @

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Toll Free (US):+1-866-598-1553
Website @

Media Relations Contact

Satya Prabhu
Business Developement Head
Precision Business Insights

View this press release online at: